{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T08:26:02Z","timestamp":1790670362206,"version":"4.1.0"},"reference-count":30,"publisher":"Tech Science Press","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["oncol res"],"published-print":{"date-parts":[[2016,6,7]]},"abstract":"<jats:p>It has been demonstrated that microRNAs (miRNAs) act as oncogenes or tumor suppressors in a variety of cancers. Our previous work suggested that miR-10a\/b functioned as a tumor suppressor in gastric cancer, and miR-10b was also reported to be significantly downregulated in advanced stage cervical cancer tissues. However, the aberrant expression of miR-10b in cervical cancer and its possible role in cervical carcinogenesis was largely unknown. In this study, we investigated the expression of miR-10b in cervical cancer tissues, carcinoma in situ tissues, mild dysplasia, moderate dysplasia, severe dysplasia tissues, and normal controls. We found that miR-10b was significantly downregulated during cervical cancer progression, and the lower level of miR-10b in cervical cancer was significantly associated with a more aggressive tumor phenotype. Moreover, overexpression of miR-10b in cervical cancer cells could inhibit the cell proliferation and invasion, and the further mechanism study suggested that its role was possibly through directly targeting HOXA1. These results suggested that the downregulation of miR-10b and the resulting elevated HOXA1 level in cervical cancer tissues might play critical roles in cervical cancer progression.<\/jats:p>","DOI":"10.3727\/096504016x14611963142173","type":"journal-article","created":{"date-parts":[[2016,6,7]],"date-time":"2016-06-07T02:35:15Z","timestamp":1465266915000},"page":"99-108","source":"Crossref","is-referenced-by-count":27,"title":["The Downregulation of MicroRNA-10b and its Role in Cervical Cancer"],"prefix":"10.32604","volume":"24","author":[{"given":"Dongling","family":"Zou","sequence":"first","affiliation":[{"name":"Department of Radiological Medicine, Chongqing Medical University, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaolin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"17807","reference":[{"key":"b1","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1093\/annonc\/mdr015","article-title":"Worldwide burden of cervical cancer in 2008","volume":"22","year":"2011","journal-title":"Ann. Oncol."},{"key":"b2","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/ijc.25516","article-title":"Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008","volume":"127","year":"2010","journal-title":"Int. J. Cancer"},{"key":"b3","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0305-7372(03)00068-9","article-title":"Modern management of locally advanced cervical carcinoma","volume":"29","year":"2003","journal-title":"Cancer Treat. Rev."},{"key":"b4","doi-asserted-by":"crossref","first-page":"5761","DOI":"10.1038\/onc.2010.352","article-title":"MicroRNA dysregulation in gastric cancer: A new player enters the game","volume":"29","year":"2010","journal-title":"Oncogene"},{"key":"b5","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13048-015-0162-2","article-title":"MicroRNAs in ovarian function and disorders","volume":"8","year":"2015","journal-title":"J. Ovarian Res."},{"key":"b6","first-page":"1773","article-title":"miR-32 functions as a tumor suppressor and directly targets SOX9 in human non-small cell lung cancer","volume":"8","year":"2015","journal-title":"Onco. Targets Ther."},{"key":"b7","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1002\/ijc.22394","article-title":"Expression profiling identifies microRNA signature in pancreatic cancer","volume":"120","year":"2007","journal-title":"Int. J. Cancer"},{"key":"b8","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1038\/sj.onc.1209283","article-title":"Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues","volume":"25","year":"2006","journal-title":"Oncogene"},{"key":"b9","doi-asserted-by":"crossref","first-page":"6015","DOI":"10.1158\/0008-5472.CAN-09-4531","article-title":"miRNA-96 suppresses KRAS and functions as a tumor suppressor gene in pancreatic cancer","volume":"70","year":"2010","journal-title":"Cancer Res."},{"key":"b10","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jhep.2010.02.021","article-title":"MicroRNA-21 acts as an oncomir through multiple targets in human hepatocellular carcinoma","volume":"53","year":"2010","journal-title":"J. Hepatol."},{"key":"b11","doi-asserted-by":"crossref","first-page":"8065","DOI":"10.1007\/s13277-015-3483-2","article-title":"MicroRNA-142-3p inhibits cell proliferation and invasion of cervical cancer cells by targeting FZD7","volume":"36","year":"2015","journal-title":"Tumour Biol."},{"key":"b12","doi-asserted-by":"crossref","first-page":"11933","DOI":"10.1007\/s13277-014-2479-7","article-title":"Mir-155 promotes cervical cancer cell proliferation through suppression of its target gene LKB1","volume":"35","year":"2014","journal-title":"Tumour Biol."},{"key":"b13","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12943-015-0385-2","article-title":"Alterations in microRNAs miR-21 and let-7a correlate with aberrant STAT3 signaling and downstream effects during cervical carcinogenesis","volume":"14","year":"2015","journal-title":"Mol. Cancer"},{"key":"b14","doi-asserted-by":"crossref","first-page":"e0127109","DOI":"10.1371\/journal.pone.0127109","article-title":"Up-regulation of miR-21 is associated with cervicitis and human papillomavirus infection in cervical tissues","volume":"10","year":"2015","journal-title":"PLoS One"},{"key":"b15","first-page":"304584","article-title":"miR-34a and miR-125b expression in HPV infection and cervical cancer development","volume":"2015","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"b16","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1002\/ijc.29618","article-title":"A systematic study on dysregulated microRNAs in cervical cancer development","volume":"138","year":"2016","journal-title":"Int. J. Cancer"},{"key":"b17","doi-asserted-by":"crossref","first-page":"e88057","DOI":"10.1371\/journal.pone.0088057","article-title":"MicroRNA-10a is down-regulated by DNA methylation and functions as a tumor suppressor in gastric cancer cells","volume":"9","year":"2014","journal-title":"PLoS One"},{"key":"b18","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s10120-014-0340-8","article-title":"DNA methylation downregulated mir-10b acts as a tumor suppressor in gastric cancer","volume":"18","year":"2015","journal-title":"Gastric Cancer"},{"key":"b19","doi-asserted-by":"crossref","first-page":"e33762","DOI":"10.1371\/journal.pone.0033762","article-title":"Downregulation of six microRNAs is associated with advanced stage, lymph node metastasis and poor prognosis in small cell carcinoma of the cervix","volume":"7","year":"2012","journal-title":"PLoS One"},{"key":"b20","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1245\/s10434-012-2252-3","article-title":"MicroRNA-10a is overexpressed in human pancreatic cancer and involved in its invasiveness partially via suppression of the HOXA1 gene","volume":"19","year":"2012","journal-title":"Ann. Surg. Oncol."},{"key":"b21","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nature06174","article-title":"Tumour invasion and metastasis initiated by microRNA-10b in breast cancer","volume":"449","year":"2007","journal-title":"Nature"},{"key":"b22","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/bcr2720","article-title":"Role of miR-10b in breast cancer metastasis","volume":"12","year":"2010","journal-title":"Breast Cancer Res."},{"key":"b23","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1002\/ijc.24522","article-title":"MicroRNA-10b is overexpressed in malignant glioma and associated with tumor invasive factors, uPAR and RhoC","volume":"125","year":"2009","journal-title":"Int. J. Cancer"},{"key":"b24","doi-asserted-by":"crossref","first-page":"740","DOI":"10.4161\/epi.6.6.15874","article-title":"Epigenetic regulation of microRNA-10b and targeting of oncogenic MAPRE1 in gastric cancer","volume":"6","year":"2011","journal-title":"Epigenetics"},{"key":"b25","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1111\/j.1349-7006.2010.01650.x","article-title":"Circulating microRNA in body fluid: A new potential biomarker for cancer diagnosis and prognosis","volume":"101","year":"2010","journal-title":"Cancer Sci."},{"key":"b26","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nrclinonc.2011.76","article-title":"MicroRNAs in body fluids the mix of hormones and biomarkers","volume":"8","year":"2011","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"b27","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ygyno.2008.04.033","article-title":"MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer","volume":"110","year":"2008","journal-title":"Gynecol. Oncol."},{"key":"b28","doi-asserted-by":"crossref","first-page":"5078","DOI":"10.1073\/pnas.0600587103","article-title":"MicroRNA fingerprints during human megakaryocytopoiesis","volume":"103","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"b29","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1349-7006.2003.tb01461.x","article-title":"Homeobox gene expression and mutation in cervical carcinoma cells","volume":"94","year":"2003","journal-title":"Cancer Sci."},{"key":"b30","first-page":"3045","article-title":"Profiling of differentially expressed genes in human primary cervical cancer by complementary DNA expression array","volume":"4","year":"1998","journal-title":"Clin. Cancer Res."}],"container-title":["Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.techscience.com\/uploads\/attached\/file\/20240531\/20240531094928_42153.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T21:32:58Z","timestamp":1733520778000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.techscience.com\/or\/v24n2\/56955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,7]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,6,7]]}},"alternative-id":["0965-0407(20160607)24:2L.99;1-"],"URL":"https:\/\/doi.org\/10.3727\/096504016x14611963142173","relation":{},"ISSN":["0965-0407"],"issn-type":[{"value":"0965-0407","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6,7]]}}}